CN215134927U - Wearable drug delivery device for clinical care - Google Patents

Abstract

The utility model provides a wearable device of dosing for clinical care. The injection device at least comprises an infusion system and a bottom belt, wherein the infusion system is arranged in a mode that medicines can be conveyed to an injection assembly from a conveying assembly through a valve, the valve is connected with the conveying assembly and the injection assembly through a conduit, the bottom belt is provided with the valve and at least two containing bags capable of containing the conveying assembly, the bottom belt is connected with at least two fixing belts, the fixing belts are provided with limiting holes, and the limiting holes are arranged in a mode that the conduit connecting the injection assembly and the valve can be contained. The utility model provides a wearable device of dosing for clinical care is convenient for carry, do not influence patient's work and rest and can realize long-time continuous work.

Description

Wearable drug delivery device for clinical care

Technical Field

The utility model relates to the field of medical equipment, especially, relate to a wearable device of dosing for clinical care.

Background

Pain patients need to take pain relievers outside the dura mater of cervical vertebra, thoracic vertebra or lumbar vertebra after epidural catheter operation. The drug is generally administered continuously by means of an electronic infusion pump for a prolonged period of time, said prolonged period of time generally lasting about 2 weeks with uninterrupted infusion at 24 hours throughout the day. The pump is usually provided with a reservoir with a volume of 250ml, resulting in a heavy weight, but in order to avoid interrupting the injection at night, the patient sometimes needs to carry two sets of identical devices, which are back-up to each other. Therefore, the electronic infusion pump device which is convenient to carry, does not influence the work and rest of the patient and can continuously work for a long time is urgently needed in the current clinical care.

The patent that publication is CN212574235U discloses a thoracic surgery patient postoperative clothing of going out, including sleeveless jacket, the front side middle part opening of sleeveless jacket passes through the zip fastener and connects, the left lower part of front side of sleeveless jacket can be dismantled and is connected with analgesia pump arrangement bag, the right lower part of front side of sleeveless jacket is equipped with a plurality of pocket, the surface of analgesia pump arrangement bag and pocket is equipped with the couple, the top that sleeveless jacket corresponds analgesia pump arrangement bag and pocket is equipped with wiring portion respectively, wiring portion includes a plurality of horizontally distributed's wiring buckle, each wiring buckle is set up by two semicircle ring arc opposite directions. When the patient lies in bed, the analgesia pump placing bag can be hung at the bedside, so that the storage is facilitated, and the pressure injury to the patient is avoided; settle the bag with the analgesia pump and hang on sleeveless jacket during the trip, in the pocket was placed to stomach intestine decompression ball and mediastinum drainage ball, infusion bag, thorax drainage bottle and urine bag hung on the couple, the connecting pipe winding was on a plurality of wiring buckles, and the external effort to the connecting pipe is weakened through a plurality of wiring buckles, effectively avoids the connecting pipe to drop.

The patent with publication number CN206391365U discloses a wearable microneedle drug delivery device, which comprises a microneedle drug delivery mechanism and a wearing mechanism for wearing the microneedle drug delivery mechanism; the wearing mechanism is a bracelet, a bracelet and a glove, wherein the microneedle feeding mechanism comprises a microneedle, a micro motor, a micro pump, a medicine storage pool, a feeding ring and a power supply, and the micro motor is connected with the microneedle to provide acting force of the microneedle acting on the skin; the micro pump is connected with the medicine storage pool and is used for conveying liquid medicine; the drug administration ring is contacted with the skin to keep continuous drug administration; the power supply is used for supplying power to the micro motor and the micro pump. The utility model fixes the micro-needle drug delivery mechanism on one part for drug delivery in the mode of a bracelet, a bracelet and a glove, and is simple and convenient to use; the administration dosage is not limited by the size of the microneedle, and the application range of the microneedle permeation promotion is expanded; the intelligent drug delivery design can realize continuous drug delivery.

The patent with publication number CN212547832U discloses an analgesia pump portable arm bag, wherein the analgesia pump comprises a liquid storage bottle, an infusion tube and a control valve, the infusion tube sequentially communicates the liquid storage bottle and the control valve, the analgesia pump portable arm bag comprises a bag body, a containing bag, a fixing component and a containing mechanism, and the bag body is used for containing the liquid storage bottle; the containing bag is arranged on the front side of the bag body to contain the control valve; the fixing components are arranged on the bag body and positioned at two sides of the containing bag, and are used for fixing the bag body on the arm of a user; the storage mechanism is fixed on the outer wall of the bag body and located below the storage bag, wherein when the liquid storage bottle is contained in the bag body, the infusion tube extends out of the bottom of the bag body and is wound and fixed on the storage mechanism and connected with the control valve. Therefore, when the patient needs to turn over or get up to move on the sickbed, the analgesia pump can move or be carried along with the patient, the needle is prevented from being pulled, and the safety is higher.

The utility model discloses improve prior art, design a wearable device of dosing for clinical care portable, do not influence patient's work and rest, can last work for a long time.

Furthermore, on the one hand, due to the differences in understanding to the person skilled in the art; on the other hand, since the inventor studied a lot of documents and patents when making the present invention, but the space did not list all details and contents in detail, however, this is by no means the present invention does not possess these prior art features, but on the contrary the present invention has possessed all features of the prior art, and the applicant reserves the right to increase the related prior art in the background art.

SUMMERY OF THE UTILITY MODEL

To prior art not enough, the utility model provides a wearable device of dosing for clinical care, at least including infusion system and base band, infusion system sets up to injection unit's mode according to can carrying the medicine behind the valve from transport assembly, wherein, the valve pass through the pipe with transport assembly and injection unit connects, the base band is provided with valve and at least two can hold transport unit's the bag that holds, the base band is connected with two at least fixed bands, be provided with about hole on the fixed band, about hole according to can holding the connection injection assembly with the valve the mode of pipe sets up.

According to a preferred embodiment, the containing bag comprises a first containing bag and a second containing bag, the delivery assembly comprises a first delivery assembly and a second delivery assembly, the first delivery assembly placed in the first containing bag is connected to the valve through a first conduit and then connected to the injection assembly through a third conduit to form a first infusion system, and the second delivery assembly placed in the second containing bag is connected to the valve through a second conduit and then connected to the injection assembly through a third conduit to form a second infusion system.

According to a preferred embodiment, the first and second delivery assemblies are identical in structure, the first delivery assembly comprises at least an infusion pump, a medication chamber and a delivery tube, the delivery tube is connected with a first conduit, and the infusion pump is capable of pumping the medication in the medication chamber to the delivery tube and then to the first conduit.

According to a preferred embodiment, the valve is connected to a first, a second and a third conduit, respectively, and at the same time it conducts only the first and the third conduit or the second and the third conduit.

According to a preferred embodiment, at least two restriction holes are arranged on the fixing belt, and a space is reserved between the restriction holes.

According to a preferred embodiment, the injection assembly comprises at least a drug delivery port, an injection tube and a sterile dressing, wherein the drug delivery port is arranged inside the sterile dressing, a first end of the injection tube is connected with the drug delivery port, and a second end of the injection tube extends out of the sterile dressing to be connected with a third catheter.

According to a preferred embodiment, the restriction hole is disposed on the first end surface of the fixing strip at a position away from the edge in the middle of the fixing strip.

According to a preferred embodiment, the two fastening tapes are arranged in such a way that in case of use of the drug delivery device by the patient, the fastening tapes in the front chest position are parallel and the fastening tapes in the back position are staggered.

According to a preferred embodiment, the valve is located in the middle of the bottom belt, and the valve is fixedly connected with the bottom belt.

According to a preferred embodiment, the first and second containing pockets are arranged on both sides of the valve.

The utility model provides a pair of wearable device of dosing for clinical care has following one or more advantages at least:

(1) the utility model realizes 24 hours uninterrupted administration throughout the day by the configuration mode of two sets of infusion systems under the condition that the patient needs to administer the medicine for a long time;

(2) the utility model prevents the drug delivery device from increasing load on the lumbar vertebra and the cervical vertebra of the patient by arranging the delivery component on the bottom belt under the condition that the patient lies;

(3) the utility model guides the administration pipeline by arranging the restriction hole, thereby avoiding the pipeline from dropping off due to the traction of the patient;

(4) the utility model discloses a micropin is dosed to the aseptic environment is guaranteed in the mode of aseptic dressing inside with injecting the micropin setting, reduces patient's wound and infects the risk.

Drawings

Fig. 1 is a schematic view of a preferred wearable drug delivery device for clinical care of the present invention;

fig. 2 is a schematic view of a fixing band according to a preferred embodiment of the present invention;

FIG. 3 is a schematic view of a preferred embodiment of the delivery assembly of the present invention;

FIG. 4 is a schematic view of an injection assembly of a preferred embodiment of the present invention;

fig. 5 is a schematic view of a restriction hole according to a preferred embodiment of the present invention.

List of reference numerals

100: the drug delivery device 110: first conveyance assembly 111: infusion pump

112: the medicine chamber 113: delivery pipe 120: second conveying assembly

130: the conduit 131: first conduit 132: a second conduit

133: third conduit 140: injection assembly 141: drug delivery port

142: the injection tube 143: sterile dressing 151: bottom belt

152: first receiving bag 153: second receiving bag 154: fixing belt

155: the restriction hole 160: valve gate

Detailed Description

The following detailed description is made with reference to the accompanying drawings.

In the description of the present invention, it is to be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, and are only for convenience of description and to simplify the description, but do not indicate or imply that the device or element referred to must have a particular orientation, be constructed and operated in a particular orientation, and therefore should not be construed as limiting the present invention.

As shown in fig. 1, the present invention provides a wearable drug delivery device 100 for clinical care. Including at least the infusion system and the bottom band 151. The infusion system is configured to deliver the drug from the delivery assembly to the injection assembly 140 through the valve 160. Valve 160 is connected to the delivery assembly and injection assembly 140 by conduit 130. The bottom belt 151 is provided with a valve 160 and at least two receiving pockets capable of receiving the transport assembly. At least two fixing straps 154 are connected to the bottom strap 151. The fixing band 154 is provided with a restriction hole 155. The restraining aperture 155 is configured to receive the conduit 130 connecting the syringe assembly 140 and the valve 160.

Preferably, the receiving bag includes a first receiving bag 152 and a second receiving bag 153. The conveyor assembly includes a first conveyor assembly 110 and a second conveyor assembly 120. The first delivery assembly 110 disposed in the first containment bag 152 is connected to the valve 160 via the first conduit 131 and connected to the injection assembly 140 via the third conduit 133 to form a first infusion system. The second delivery assembly 120, disposed in the second containment bag 153, is connected to the valve 160 via the second conduit 132 and to the injection assembly 140 via the third conduit 133 to form a second infusion system.

Preferably, the valves 160 are connected to the first, second and third conduits 131, 132 and 133, respectively. At the same time, the valve 160 conducts only the first conduit 131 and the third conduit 133 or the second conduit 132 and the third conduit 133.

Preferably, the valve 160 is located in the middle of the bottom band 151, and the valve 160 is fixedly connected to the bottom band 151. Preferably, the first receiving bag 152 and the second receiving bag 153 are disposed at both sides of the valve 160. Preferably, the fixing band 154 is provided with at least two binding holes 155, and there is a space between the binding holes 155. Preferably, the restriction hole 155 is formed at the first end surface of the fixing band 154 at a position far from the edge in the middle of the fixing band 154.

Referring to fig. 2, fig. 2 is a schematic view of a fixing band according to a preferred embodiment of the present invention. Preferably, the two securing straps 154 are arranged such that, in a situation where the patient uses the drug delivery device 100, the securing straps 154 in the chest position are parallel and the securing straps 154 in the back position are staggered.

Preferably, the bottom band 151 is provided to the chest and abdomen portion of the human body. Preferably, the first and second receiving pockets 152 and 153 are provided at both ends of the bottom tape 151. After the first and second receiving bags 152 and 153 are placed in the first and second delivery assemblies 110 and 120, the delivery assemblies are positioned on the abdomen of the patient without discomfort when the patient is lying on his or her side. Preferably, the drug delivery device 100 is secured to the patient by a securing strap 154. One end of the fixing band 154 is connected to a first edge of the base band 151. The second end of the securing strap 154 is attached to the second edge of the bottom strap 151 behind the back and over the shoulders of the patient. Preferably, the fixing band 154 is detachably coupled with the base band 151. Preferably, the connection means may be by a snap connection. Preferably, the two securing straps 154 are interleaved with each other on the back of the patient. Preferably, the drug delivery device 100 is placed on the patient in a pendant-like fashion by being wrapped with a securing strap 154. The patient can not influence the patient to lie down, lie on one side and turn over under the condition of using the drug delivery device 100 provided by the utility model. Preferably, the fixing band 154 is made of soft cloth. The securing strap 154 is configured to adjust its length to the patient's size so that the medication delivery device is secured to the patient. Preferably, the fixing band 154 is provided with a length adjustment mechanism so that the length of the fixing band can be adjusted according to the patient's body size. Preferably, the length adjustment mechanism may be a turnbuckle.

Referring to fig. 3, fig. 3 is a schematic view of a delivery assembly according to a preferred embodiment of the present invention. First delivery assembly 110 includes at least an infusion pump 111, a medication chamber 112, and a delivery tube 113. The delivery tube 113 in the first delivery assembly 110 is connected to a first conduit 131. Infusion pump 111 in first delivery assembly 110 is capable of pumping the drug in drug chamber 112 to delivery tube 113 for delivery to first conduit 131. Preferably, the first conveyor assembly 110 and the second conveyor assembly 120 are identical in construction. Second delivery assembly 110 includes at least an infusion pump 111, a medication chamber 112, and a delivery tube 113. The delivery tube 113 in the second delivery assembly 120 is connected to a second conduit 132. Infusion pump 111 in second delivery assembly 120 is capable of pumping the drug in drug chamber 112 to delivery tube 113 for delivery to second conduit 132.

Preferably, the delivery assembly is integrally formed by infusion pump 111, chamber 112 and delivery tube 113. Preferably, the delivery tube 113 of the first delivery assembly 110 is removably connected to the first conduit 131. Preferably, the delivery tube 113 of the second delivery assembly 120 is removably coupled to the second conduit 132. Preferably, the infusion pump 111 is configured with a power source and control buttons. Preferably, the user can set the mode of operation of the infusion pump 111 by means of a control button. Preferably, infusion pump 111 includes at least two modes of operation, timed administration and continuous administration. Preferably, the timed administration mode of operation is such that infusion pump 111 pumps a quantity of medication from medication chamber 112 into delivery tube 113 at intervals. Preferably, the continuous administration mode refers to the infusion pump 111 continuously pumping a certain amount of medicine from the medicine chamber 112 to the delivery pipe 113 for a certain period of time. The time and the amount of the medicine are determined by medical staff.

Referring to fig. 4, fig. 4 is a schematic view of an injection assembly according to a preferred embodiment of the present invention. Preferably, injection assembly 140 includes at least an administration port 141, a syringe 142, and a sterile dressing 143. The administration port 141 is disposed with the interior of a sterile dressing 143. A first end of syringe 142 is connected to administration port 141. A second end of the syringe 142 extends out of the sterile dressing 143 to connect with the third conduit 133.

Preferably, when the patient uses the drug delivery device provided by the present invention, the patient can conduct the first conduit 131 and the third conduit 133 through the valve 160, and simultaneously close the second conduit 132, so that the first infusion system works. In the event that the first infusion system is depleted of drug, the patient is able to conduct the second conduit 132 and the third conduit 133 through the valve 160 while blocking the first conduit 131, allowing the second infusion system to operate for uninterrupted administration. In the event that the first infusion system is depleted of medication and the second infusion system has been enabled, the patient is able to replace the first delivery assembly 110 in the first infusion system. In the event that the second infusion system is depleted of medication, the patient is able to conduct the first conduit 131 and the third conduit 133 through the valve 160 while closing the second conduit 132, allowing the first infusion system to operate for uninterrupted administration of medication. In the event that the second infusion system is depleted of medication and the first infusion system has been enabled, the patient is able to replace the second delivery assembly 120 in the second infusion system.

The fixing band 154 is provided with a plurality of spaced constraining holes 155. Preferably, the binding hole 155 is axially disposed along the fixing band 154. Preferably, the two constraining holes 155 are equally spaced. Preferably, the restraining holes 155 are evenly distributed on the securing straps 154. Preferably, a first end of the third conduit 133 is connected to the valve 160. The second end of the third conduit 133 extends through a plurality of restraining holes 155 formed in the refastenable band 151 and out of the restraining hole 155 located closest to the wound of the patient, and is then connected to the placement module 140 at the wound.

For easy understanding, the working principle of the wearable drug delivery device for clinical care of the present invention is explained.

The utility model relates to a wearable drug delivery device for clinical care, which adopts a chest-hang type design, two sets of delivery components are placed on the chest and abdomen of a patient, and the drug delivery device is kept on the human body through a fixing band; the valve controls the work of the injection assembly to realize continuous administration; the guide and the restraint of the catheter are realized through the restraint holes arranged on the fixing belt; the conveying component is designed in an integrated manner and is convenient to replace; the two sets of conveying assemblies are combined with the guide pipe and the valve to form two sets of infusion systems, and the two sets of infusion systems alternately work to realize uninterrupted work; the administration port is disposed within the sterile dressing, ensuring a sterile environment for the injection assembly.

It should be noted that the above-mentioned embodiments are exemplary, and that those skilled in the art, having benefit of the present disclosure, may devise various arrangements that are within the scope of the present disclosure and that fall within the scope of the invention. It should be understood by those skilled in the art that the present specification and figures are illustrative only and are not limiting upon the claims. The scope of the invention is defined by the claims and their equivalents.

Claims (10)

1. A wearable drug delivery device for clinical care, characterized by comprising at least an infusion system and a bottom belt (151),

the infusion system is arranged in such a way that it is capable of delivering a drug from a delivery assembly to an injection assembly (140) via a valve (160), wherein the valve (160) is connected to the delivery assembly and to the injection assembly (140) via a conduit (130),

the bottom belt (151) is provided with the valve (160) and at least two containing bags capable of containing the conveying assembly, the bottom belt (151) is connected with at least two fixing belts (154), the fixing belts (154) are provided with constraint holes (155), and the constraint holes (155) are arranged in a mode of containing the guide pipe (130) which is connected with the injection assembly (140) and the valve (160).

2. The wearable drug delivery device for clinical care according to claim 1, characterized in that the receiving bag comprises a first receiving bag (152) and a second receiving bag (153), and the transport assembly comprises a first transport assembly (110) and a second transport assembly (120),

a first delivery assembly (110) placed in a first containment bag (152) is connected to a valve (160) by a first conduit (131) and to an injection assembly (140) by a third conduit (133) to form a first infusion system,

the second delivery assembly (120) placed in the second receiving bag (153) is connected to the valve (160) through the second conduit (132) and then connected to the injection assembly (140) through the third conduit (133) to constitute a second infusion system.

3. The wearable drug delivery device for clinical care according to claim 2, characterized in that the first delivery assembly (110) and the second delivery assembly (120) are identical in structure, the first delivery assembly (110) comprising at least an infusion pump (111), a drug chamber (112) and a delivery tube (113), the delivery tube (113) being connected to a first catheter (131),

the infusion pump (111) is capable of pumping the drug in the drug chamber (112) to a delivery tube (113) and then to a first conduit (131).

4. The wearable drug delivery device for clinical care according to claim 3, characterized in that the valve (160) is connected to the first conduit (131), the second conduit (132) and the third conduit (133), respectively,

at the same time, a valve (160) conducts only the first conduit (131) and the third conduit (133) or conducts the second conduit (132) and the third conduit (133).

5. The wearable clinical care drug delivery device according to claim 4, characterized in that the fixing band (154) is provided with at least two restriction holes (155), and the restriction holes (155) are spaced apart from each other.

6. The wearable drug delivery device for clinical care according to claim 5, characterized in that the injection assembly (140) comprises at least a drug delivery port (141), a syringe (142) and a sterile dressing (143), wherein,

the administration port (141) is arranged inside the sterile dressing (143), a first end of the injection tube (142) is connected with the administration port (141), and a second end of the injection tube (142) extends out of the sterile dressing (143) to be connected with a third conduit (133).

7. The wearable clinical care drug delivery device according to claim 6, wherein the restraining hole (155) is provided at the first end surface of the securing strap (154) at a position away from the edge in the middle of the securing strap (154).

8. The wearable clinical care medication delivery device according to claim 7, wherein the two fastening bands (154) are arranged side-by-side with the fastening band (154) in the chest position and the fastening bands (154) in the back position staggered with respect to each other in use of the medication delivery device by the patient.

9. The wearable drug delivery device for clinical care according to claim 8, characterized in that the valve (160) is located in the middle of the bottom belt (151), the valve (160) is fixedly connected to the bottom belt (151), and the first receiving bag (152) and the second receiving bag (153) are disposed on both sides of the valve (160).

10. The wearable medication delivery device for clinical care according to claim 9, characterized in that the securing strap (154) is arranged in such a way that it can adjust its length according to the patient's size so that the medication delivery device is secured to the patient.

Images